The epigenetic regulation of imprinted genes by monoallelic DNA methylation of either maternal or paternal alleles is critical for embryonic growth and development 1 . Imprinted genes were recently shown to be expressed in mammalian adult stem cells to support self-renewal of neural and lung stem cells [2] [3] [4] ; however, a role for imprinting per se in adult stem cells remains elusive. Here we show upregulation of growth-restricting imprinted genes, including in the H19-Igf2 locus 5 , in long-term haematopoietic stem cells and their downregulation upon haematopoietic stem cell activation and proliferation. A differentially methylated region upstream of H19 (H19-DMR), serving as the imprinting control region, determines the reciprocal expression of H19 from the maternal allele and Igf2 from the paternal allele 1 . In addition, H19 serves as a source of miR-675, which restricts Igf1r expression 6 . We demonstrate that conditional deletion of the maternal but not the paternal H19-DMR reduces adult haematopoietic stem cell quiescence, a state required for long-term maintenance of haematopoietic stem cells, and compromises haematopoietic stem cell function. Maternal-specific H19-DMR deletion results in activation of the Igf2-Igfr1 pathway, as shown by the translocation of phosphorylated FoxO3 (an inactive form) from nucleus to cytoplasm and the release of FoxO3-mediated cell cycle arrest, thus leading to increased activation, proliferation and eventual exhaustion of haematopoietic stem cells. Mechanistically, maternal-specific H19-DMR deletion leads to Igf2 upregulation and increased translation of Igf1r, which is normally suppressed by H19-derived miR-675. Similarly, genetic inactivation of Igf1r partly rescues the H19-DMR deletion phenotype. Our work establishes a new role for this unique form of epigenetic control at the H19-Igf2 locus in maintaining adult stem cells.
The epigenetic regulation of imprinted genes by monoallelic DNA methylation of either maternal or paternal alleles is critical for embryonic growth and development 1 . Imprinted genes were recently shown to be expressed in mammalian adult stem cells to support self-renewal of neural and lung stem cells [2] [3] [4] ; however, a role for imprinting per se in adult stem cells remains elusive. Here we show upregulation of growth-restricting imprinted genes, including in the H19-Igf2 locus 5 , in long-term haematopoietic stem cells and their downregulation upon haematopoietic stem cell activation and proliferation. A differentially methylated region upstream of H19 (H19-DMR), serving as the imprinting control region, determines the reciprocal expression of H19 from the maternal allele and Igf2 from the paternal allele 1 . In addition, H19 serves as a source of miR-675, which restricts Igf1r expression 6 . We demonstrate that conditional deletion of the maternal but not the paternal H19-DMR reduces adult haematopoietic stem cell quiescence, a state required for long-term maintenance of haematopoietic stem cells, and compromises haematopoietic stem cell function. Maternal-specific H19-DMR deletion results in activation of the Igf2-Igfr1 pathway, as shown by the translocation of phosphorylated FoxO3 (an inactive form) from nucleus to cytoplasm and the release of FoxO3-mediated cell cycle arrest, thus leading to increased activation, proliferation and eventual exhaustion of haematopoietic stem cells. Mechanistically, maternal-specific H19-DMR deletion leads to Igf2 upregulation and increased translation of Igf1r, which is normally suppressed by H19-derived miR-675. Similarly, genetic inactivation of Igf1r partly rescues the H19-DMR deletion phenotype. Our work establishes a new role for this unique form of epigenetic control at the H19-Igf2 locus in maintaining adult stem cells.
Our earlier studies showed that imprinted genes, including those within the H19-Igf2 locus (Fig. 1a) , are differentially expressed in haematopoietic stem and progenitor cells (HSPCs) 7 . To explore this further, we systematically analysed imprinted gene expression in quiescent-enriched longterm haematopoietic stem cells (LT-HSCs), more active short-term (ST)-HSCs and multipotent progenitor (MPP) populations (Fig. 1b) 8 . Out of 88 imprinted genes, 23 were differentially expressed in these populations. Of these 23, 15 were preferentially expressed in LT-HSCs, whereas the others were predominantly expressed in ST-HSCs and MPPs (Fig. 1c) . Intriguingly, 80% of the imprinted genes with predominant expression in LT-HSCs were associated with growth restriction, including H19, Cdkn1c/p57, Ndn, Rb, Gtl2 and Grb10 (ref. 9 ). In contrast, imprinted genes expressed preferentially in ST-HSCs and MPPs, including Ascl2, Peg12, Sfmbt2, Pon3, Atp10a and Osbpl5, were associated with growth promotion and increased metabolism 10 (see quantitative real-time PCR assay in Supplementary Fig. 1a) .
Given the critical role of H19 during embryonic development and its preferential expression in LT-HSCs, we considered that it plays a role in restricting LT-HSC activation. To test this idea, we conditionally deleted H19-DMR (an epigenetic regulator that controls expression of H19) by breeding H19 flDMR/flDMR mice with Mx1-Cre mice to generate maternal (mH19
) and paternal (pH19
) allele-specific mutants ( Supplementary Fig. 1b) . The DMR region was deleted with 100% efficiency in LT-HSC ( Supplementary Fig. 1c , e-g) 11 . As early as 6 weeks, flow cytometric analysis showed a substantial decrease in frequency and absolute number of LT-HSCs in mH19 DDMR/1 mice ( Fig. 1 d-f and Supplementary Fig. 1d ), but not in pH19 DDMR/1 mice ( Fig. 1e and Supplementary Fig. 2a, b) . Concurrently, we observed a significant increase in frequency and absolute number of ST-HSCs ( Fig. 1d-f) ; however, the total number of bone marrow cells remained unchanged (Fig. 1g) . By 6 months, both LT-and ST-HSCs were significantly decreased in frequency and absolute number, whereas bone marrow cellularity increased only in mH19 DDMR/1 mice (Fig. 1d-g and Supplementary Fig. 2c, d) .
Cell cycle analysis of LT-HSCs at 6 weeks after pIpC induction showed a decrease in the G0 phase fraction and a concomitant increase in the G1 phase fraction in mH19 DDMR/1 relative to control ( Fig. 1h-j) . We then tested the response of mH19 DDMR/1 mice to bone marrow damage by administering 5-fluorouracil (5FU), which eliminates active HSPCs while sparing quiescent HSCs. Surviving quiescent HSCs later replenish lost HSPCs 12 ( Fig. 1k) . In this context, a significant reduction in quiescent HSCs after three cycles of 5FU treatment led to deficient bone marrow recovery in the mH19 DDMR/1 mutant compared with control (Fig. 1l, m and Supplementary Fig. 2f ). Altogether, maternal but not paternal deletion of H19-DMR resulted in loss of HSC quiescence, leading to progressive loss of LT-HSCs and then ST-HSCs, accompanied by increasing progenitor cell proliferation and differentiation, thus ultimately increasing total bone marrow cellularity ( Fig. 1g and Supplementary Figs 2e and 3a-d) .
To characterize the phenotype functionally, we transplanted equal numbers of sorted LT-HSCs from mutants and their control littermates. We observed a significant reduction in reconstitution ability for LT-HSCs derived from mH19 DDMR/1 but not pH19 DDMR/1 mutants compared with controls. Although overall engraftment was reduced in primary and secondary recipients, no mature lineage bias was apparent ( Fig. 2a-f ). Limiting dilution analysis to quantify functional HSCs showed a 2.5-fold decrease in mH19 DDMR/1 mutant HSCs relative to control (Fig. 2d) . Reciprocal transplantation of wild-type donor cells into either mH19
DDMR/1 or control recipients did not result in alterations in haematopoiesis (Fig. 2g, h ), indicating that an intrinsic change in the mH19 DDMR/1 mutant HSCs was the primary cause of the phenotype. Next, we investigated whether H19-DMR controls the imprinted expression of H19 and Igf2 from the maternal and paternal alleles, respectively, in adult HSCs, as is observed in embryos HSCs (Fig. 3a, b) . By crossing H19 flDMR/1 females with Mus castaneus (Cast) males, which enables parental allele-discrimination by single nucleotide polymorphism analysis, we further detected exclusive expression of Igf2 from the paternal allele in HSCs (Fig. 3c) . However, after deletion of the maternal H19-DMR, we detected H19 downregulation and Igf2 upregulation, which resulted from biallelic Igf2 expression in HSCs (Fig. 3d-f) . Igf2 was similarly upregulated in bone marrow, including surrounding stromal cells, after maternal deletion of H19-DMR (Fig. 3g, h) . Igf2 and Igf1r amounts were gradually increased from LT-HSCs to MPPs (Fig. 3i, j) . However, messenger RNA (mRNA), protein concentrations, and the number of Igf1r 1 cells were significantly increased in mH19 DDMR/1 LT-HSCs compared with controls ( Fig. 3k-m) , with no change in Igf2r expression (Fig. 3k) . Igf2-Igf1r signalling is known to activate PI3K-Akt, which phosphorylates and inactivates FoxO3, a transcription factor that arrests the cell cycle 15, 16 . Inactive pFoxO3 was detected in only 15% of normal LT-HSCs but was substantially increased in ST-HSCs and MPPs (Fig. 3n, o) ; however, in mH19 DDMR/1 pFoxO3 was detected in 75% of LT-HSCs. Our data indicate that H19-DMR deletion increased Igf2 
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signalling, which released FoxO3-mediated suppression of HSC activation and proliferation.
In the placenta, H19 functions as a precursor of miR-675, which in turn suppresses Igf1r 6 . We next investigated whether this regulation exists in adult HSCs. Expression of miR-675 was highest in LT-HSCs in the control mice but was substantially reduced in mH19
LT-HSCs (Fig. 4a) 1 LSK cells (Fig. 4b) . Western blot analysis showed a significant reduction of Igf1r by miR-675 compared with control (Fig. 4c) . Furthermore, Igf1r amounts were lower in CD34 2 LSK compared with CD34 1 LSK cells in the control. However, miR-675 overexpression significantly decreased Igf1r (Fig. 4c-e ). These data demonstrate that H19-derived miR-675 regulates Igf1r and the corresponding quiescent state in HSCs.
To confirm further that H19-DMR controls Igf2-Igf1r signalling, we crossed female H19 flDMR/1 mice with male Mx1-Cre:Igf1r fl/fl mice ( Supplementary Fig. 4a ) 17 . Although mH19 DDMR/1 mutants (Fig. 3f, g ) showed a decrease in LT-HSCs and an increase in ST-HSCs and MPPs, 
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double mutants showed a partial restoration of LT-HSC frequency (Fig. 4f) , whereas the transition from ST-HSCs to MPPs was still blocked (Fig. 4f, g ). This indicates that Igf2-Igf1r signalling is partly responsible for the mH19 DDMR/1 phenotype. An increase in ST-HSC frequency in double-mutant mice was probably due to blocked transition from ST-HSC to MPP by downregulation of Igf1r. Furthermore, cell cycle analysis and pFoxO3 staining in double mutants showed partial rescue of the loss of quiescence phenotype (Fig. 4h, i) .
To demonstrate phenotypic rescue functionally in mH19
Igf1r 2/2 mice, we performed bone marrow transplantation assays. Although mH19 DDMR/1 mutants had significantly reduced engraftment due to LT-HSC loss, engraftment of mH19
Igf1r
2/2 bone 
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DDMR/1 and the Igf1r 2/2 single mutants, indicating a partial functional rescue ( Fig. 4j and Supplementary Fig. 4b ). These results indicate that the maternal H19-DMR controls Igf2-Igf1r signalling which regulates HSC state; however, the partial rescue indicates that deletion of H19-DMR also affects other pathways required for LT-HSC maintenance. Figs 4c and 5) . Genes involved in cell cycle arrest (Cdkn1c) 18, 19 , tumour suppression and stem cell maintenance (Ndn, Gtl2) 20, 21 were downregulated in LT-HSCs. However, Igf1r
2/2
LT-HSCs largely maintained expression patterns similar to control, with high expression amounts of Cdkn1c, Ndn, Gtl2 and Dlk1. The double mutants generally showed partial rescue of the alterations observed in single mutants, indicating either compensation in gene expression and/or existence of a proposed imprinted gene network 22, 23 ( Fig. 4k and Supplementary Fig. 4c ). Gene expression profiling of nonimprinted genes showed many overlapping downstream genes and microRNA (miRNAs) that were abnormally expressed in single mutants but partly rescued in double mutants (Fig. 4l -n and Supplementary Figs 6a-c and 7e). These included components of the Wnt and Tgf-b/BMP pathways such as Smad4, Id2 and Fzd8 (refs 24-27) as well as Let-7, which is known to repress cell proliferation 28 and Igf signalling 29 ( Fig. 4l-n) . Interestingly, H19-DMR potentially controls other miRNAs, small nucleolar RNAs (SnoRNAs) and genes (Dusp26, p2rx2 and Gpr63) independent of the Igf2-Igf1r signalling ( Supplementary Fig. 7a-f) , with a known function for Dusp26 in inhibiting cell proliferation 30 . Taken together, our data show that maternal H19-DMR primarily restricts Igf2-Igf1r signalling, but also influences other genes and miRNAs involved in maintaining HSC quiescence.
By studying the H19-DMR locus in an allele-specific manner, we demonstrate that a specialized form of epigenetic control-genomic imprinting-is critical to the maintenance of adult stem cells. This is accomplished by maintaining LT-HSC quiescence, which can be attributed largely to Igf2-Igf1r-dependent signalling, but also to extra Igf2-Igf1r-independent effects on the regulation of cell cycle, proliferation and growth.
METHODS SUMMARY
Genotyping primers, flow assays and immunostaining were reported previously 15, 26 . Lentivirus-mediated transfection used Magnetofection TM and ViroMag R/L particles (OZ Biosciences). Microarray and RNA-seq analyses used Affymetrix MouseGenome430_ 2 arrays and Illumina TruSeq RNA Sample Prep Kit (catalogue number FC-122-1001) respectively, followed by sequencing on an Illumina HiSeq 2000. Statistical analyses were performed (pairwise comparisons were performed using a Student's t-test) in Prism 5 GraphPad. . Interferon-inducible Mx1-Cre or tamoxifen-inducible Scl-Cre mouse strains were used to delete the floxed H19-DMR and Igf1r. For Mx1-Cre activation, 250 mg of pIpC was injected intraperitoneally every other day for 14 days at 5 weeks of age. For Scl-CreER activation, 2 mg of tamoxifen dissolved in 0.1 ml of corn oil was injected intraperitoneally every day for 5 days. Single-cell HSC genotyping. Single CD34 2 Flk2 2 LSK cells were sorted into 96-well plates (one cell per well) containing 50 ml MethoCult complete media (M3434; Stem Cell Technologies) and incubated (37 uC, 5% CO 2 ) for 12 days. Individual colonies were collected separately, and DNA was purified using a QIAGENamp DNA Blood Kit (Qiagen). PCR genotyping of H19 locus used G1, G5 and G7 primers described elsewhere 31 . Flow cytometry. Phenotypic analyses of haematopoietic cells collected from bone marrow (femur and tibia) and peripheral blood were performed as described previously 33, 34 . Cell sorting and analysis were performed with a MoFlo (Dako) and/or CyAn ADP (Dako). We analysed data with FlowJo software (Ashland).
5FU treatment. Cohorts of mH19
DDMR/1 and mH19 flDMR/1 were injected with 5FU (Sigma-Aldrich) at 150 mg per g (body weight) 34 4 weeks after pIpC induction. For one cycle, 5FU was injected once intravenously; for three cycles, 5FU was injected three times at 4-week intervals. Bone marrow cells were analysed 10 days after 5FU injections. were transplanted intravenously into lethally irradiated (10 Gy) Ptprc (CD45.1) recipient mice. Mice were placed on Baytril water 3 days before irradiation, which continued for 2 weeks after irradiation. Each transplanted group consisted of eight to ten recipients. Donor-derived engraftment was assayed every 4 weeks after transplantation by collection of peripheral blood, red blood cell lysis and staining of CD45.1 (recipient) versus CD45.2 (donor). Multi-lineage reconstitution was determined by CD3, B220 (for T and B lymphoid, respectively) and Gr1, Mac-1 (for myeloid) gating on donor (CD45. . Samples were analysed with Affymetrix MouseGenome430_2 arrays and scanned with a GeneChip Scanner 3000 7G using GeneChip Fluidics Station 450 and GeneChip Operating Software (GCOS 1.4). Heat map data represent the fold change between two populations from at least three independent biological samples. Three samples were run on Affymetrix Mouse 430.2 arrays in triplicate, using the standard Affymetrix protocols. CEL files were read into the R software environment (http://www.cran. r-project.org/) and normalized with RMA [37] [38] [39] . Normalized data were fitted with a linear model using the limma package 40 and three contrasts were fitted: CD34p/ CD34n, FLK2p/CD34p, FLK2p/CD34n. Probes that were significant for at least one contrast (BH adj P , 0.05) went to further analysis.
A list of imprinted genes was taken from the catalogue of imprinting genes at http://igc.otago.ac.nz/1101Summary-table.pdf. Names were matched to MGI and Ensembl 63 genes and then converted to probeset identifications. Of 125 input genes, 86 could be mapped to probesets, and, of these, 23 were significant. Sample expression coefficients per probeset were averaged together by gene. Expression amounts varied widely, from 4 to 14 in log 2 scale, which obscured the regulatory trend across samples during clustering. We constructed a heat map to show only the trending of expression, not the magnitude, by subtracting the mean from each row and dividing by the standard deviation. Thus, the heat map scale shows expression z-scores. Row ordering reflects hierarchical clustering, average linkage, using Pearson dissimilarity for distance. Microarray data have been deposited in ArrayExpress under accession number E-MTAB-1644. qRT-PCR. Total RNA (2-50 ng) was extracted from sorted LT-HSCs, ST-HSCs and MPPs directly into TRIzol H . This was followed by DNase I treatment (Ambion) and reverse transcription with a high-capacity complementary DNA (cDNA) reverse transcription kit (Applied Biosystems). cDNA was pre-amplified by TaqMan PreAmplification master mix (Applied Biosystems) according to the manufacturer's instructions. TaqMan gene expression assays (Applied Biosystems) were performed on triplicate samples with a 7500 Real-Time cycler (Applied Biosystems). Data were normalized relative to Gapdh and Hprt1. For mi-R-675-3p assay, extracted RNA were reverse transcribed using TaqMan miRNA reverse transcription kit (Applied Biosystems). TaqMan pre-amplification and TaqMan gene expression assay were performed according to the manufacturer's instructions. All qRT-PCR was performed using TaqMan probes. Immunostaining. Immunostaining was performed as described previously 33 . For immunostaining of sorted cells, cells were sorted onto lysine-coated slides, fixed with chilled methanol for 10 min, followed by blocking and staining with primary antibody 41 . The following primary antibodies were used: chicken anti Igf1r (Abcam, 1:100), rabbit anti Igf2 (Abcam, 1:100), rabbit anti FoxO3a (1:100), rabbit anti Foxo1/3/4-Pan and phosphor_Thr24/32 (Assay biotech, 1:50 
